Medtryx works with our clients to ensure their clinical study is scientifically, medically and operationally sound whilst ensuring global and local regulatory requirements are achieved. Our team have been involved in protocol design for over 100 different projects, with over 49 of these incorporating DCT and direct to patient trial methodologies.

Medtryx is Australian Owned and boasts a Sydney Headquarters. Our team have worked across a variety of roles within the Australian Clinical Research sector, and have deep experience in navigating the local regulations for successful trial delivery.

 Let our team show you the advantages of conducting your clinical research in the Australian Environment.

Medtryx are the Australian Experts in DCT clinical trial delivery, with more trials delivered than any other Australian based clinical research provider. Globally, the team at Medtryx have been involved in the executive oversight and clinical delivery of over 49 fully decentralized (direct to patient) clinical trials since 2018, 11 of these being Australian Based.

The team at Medtryx have specialized experience conducting DCT studies across 17 different therapeutic areas, each comprising a variety of different specific conditions or indications. More broadly, our non-DCT therapeutic area experience extends across all body systems.

Our team have extensive clinical trial management and monitoring experience of all phases of clinical research, including early phase, first in human trials through to post marketing and real data trials across pharmaceutical, biotech and consumer health industries.

The team at Medtryx have experience working across Asia Pacific, America, ANZ and European countries and understand the regulatory environments and operational delivery implications of working within these different regions. Our team are well placed to manage your studies on a local or global level.